The dimer interface of ERK1/2 provides a potential strategy for selective inhibition of pathological cardiac hypertrophy

被引：0
|
作者：
Tomasovic, A. [1 ]
Kramer, S. [1 ]
Huemmert, M. [1 ]
Katus, Ha [2 ]
Mueller, O. [2 ]
Lorenz, K. [3 ]
机构：
[1] Univ Wurzburg, Inst Pharmacol & Toxicol, Wurzburg, Germany
[2] Univ Hosp Heidelberg, Internal Med 3, Heidelberg, Germany
[3] Leibniz Inst Analyt Sci ISAS, Dortmund, Germany
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2017年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
810
引用
收藏
页码：187 / 187
页数：1
相关论文
共 50 条
  • [21] Maf1 ameliorates cardiac hypertrophy by inhibiting RNA polymerase III through ERK1/2
    Sun, Yu
    Chen, Cong
    Xue, Ruicong
    Wang, Yan
    Dong, Bin
    Li, Jiayong
    Chen, Chen
    Jiang, Jingzhou
    Fan, Wendong
    Liang, Zhuomin
    Huang, Hulling
    Fang, Rong
    Dai, Gang
    Yan, Youchen
    Yang, Tiqun
    Li, Xiangxue
    Huang, Zhan-Peng
    Dong, Yugang
    Liu, Chen
    THERANOSTICS, 2019, 9 (24): : 7268 - 7281
  • [22] Anti-angiogenic Potential of Scopoletin is Associated With the Inhibition of ERK1/2 Activation
    Pan, Rong
    Dai, Yue
    Yang, Jian
    Li, Ying
    Yao, Xiujuan
    Xia, Yufeng
    DRUG DEVELOPMENT RESEARCH, 2009, 70 (03) : 214 - 219
  • [23] Cardiac concentric hypertrophy promoted by activated Met receptor is mitigated in vivo by inhibition of Erk1,2 signalling with Pimasertib
    Sala, Valentina
    Gallo, Simona
    Gatti, Stefano
    Medico, Enzo
    Vigna, Elisa
    Cantarella, Daniela
    Fontani, Lara
    Natale, Massimo
    Cimino, James
    Morello, Mara
    Comoglio, Paolo Maria
    Ponzetto, Antonio
    Crepaldi, Tiziana
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2016, 93 : 84 - 97
  • [24] CYSLTR1 promotes adenoid hypertrophy by activating ERK1/2
    Gao, Wenjie
    Li, Jinying
    Li, Quanheng
    An, Shuhua
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2018, 16 (02) : 966 - 970
  • [25] Selective inhibition of angiotensin receptor signaling through Erk1/2 pathway by a novel peptide
    Liu, Jun
    Yosten, Gina L. C.
    Ji, Hong
    Zhang, Dan
    Zheng, Wei
    Speth, Robert C.
    Samson, Willis K.
    Sandberg, Kathryn
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2014, 306 (08) : R619 - R626
  • [26] A novel modification of ERK1/2 results in hypertrophy specific signaling
    Lorenz, K.
    Schmitt, J. P.
    Schmitteckert, E. M.
    Maier-Peuschel, M.
    Quitterer, U.
    Lohse, M. J.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2008, 377 : 54 - 54
  • [27] Interference with ERK-dimerization at the nucleocytosolic interface targets pathological ERK1/2 signaling without cardiotoxic side-effects
    Tomasovic, Angela
    Brand, Theresa
    Schanbacher, Constanze
    Kramer, Sofia
    Huemmert, Martin W.
    Godoy, Patricio
    Schmidt-Heck, Wolfgang
    Nordbeck, Peter
    Ludwig, Jonas
    Homann, Susanne
    Wiegering, Armin
    Shaykhutdinov, Timur
    Kratz, Christoph
    Knuechel, Ruth
    Mueller-Hermelink, Hans-Konrad
    Rosenwald, Andreas
    Frey, Norbert
    Eichler, Jutta
    Dobrev, Dobromir
    El-Armouche, Ali
    Hengstler, Jan G.
    Mueller, Oliver J.
    Hinrichs, Karsten
    Cuello, Friederike
    Zernecke, Alma
    Lorenz, Kristina
    NATURE COMMUNICATIONS, 2020, 11 (01)
  • [28] Cooperative Binding of ETS2 and NFAT Links Erk1/2 and Calcineurin Signaling in the Pathogenesis of Cardiac Hypertrophy
    Luo, Yuxuan
    Jiang, Nan
    May, Herman, I
    Luo, Xiang
    Ferdous, Anwarul
    Schiattarella, Gabriele G.
    Chen, Guihao
    Li, Qinfeng
    Li, Chao
    Rothermel, Beverly A.
    Jiang, Dingsheng
    Lavandero, Sergio
    Gillette, Thomas G.
    Hill, Joseph A.
    CIRCULATION, 2021, 144 (01) : 34 - 51
  • [29] Interference with ERK-dimerization at the nucleocytosolic interface targets pathological ERK1/2 signaling without cardiotoxic side-effects
    Angela Tomasovic
    Theresa Brand
    Constanze Schanbacher
    Sofia Kramer
    Martin W. Hümmert
    Patricio Godoy
    Wolfgang Schmidt-Heck
    Peter Nordbeck
    Jonas Ludwig
    Susanne Homann
    Armin Wiegering
    Timur Shaykhutdinov
    Christoph Kratz
    Ruth Knüchel
    Hans-Konrad Müller-Hermelink
    Andreas Rosenwald
    Norbert Frey
    Jutta Eichler
    Dobromir Dobrev
    Ali El-Armouche
    Jan G. Hengstler
    Oliver J. Müller
    Karsten Hinrichs
    Friederike Cuello
    Alma Zernecke
    Kristina Lorenz
    Nature Communications, 11
  • [30] Tetrandrine blocks cardiac hypertrophy by disrupting reactive oxygen species-dependent ERK1/2 signalling
    Shen, Di-Fei
    Tang, Qi-Zhu
    Yan, Ling
    Zhang, Yan
    Zhu, Li-Hua
    Wang, Lang
    Liu, Chen
    Bian, Zhou-Yan
    Li, Hongliang
    BRITISH JOURNAL OF PHARMACOLOGY, 2010, 159 (04) : 970 - 981
12345